KNOWN OR HIGHLY SUSPECTED BODY (EXCLUDING CNS) LESION

Clinical trials for KNOWN OR HIGHLY SUSPECTED BODY (EXCLUDING CNS) LESION explained in plain language.

Never miss a new study

Get alerted when new KNOWN OR HIGHLY SUSPECTED BODY (EXCLUDING CNS) LESION trials appear

Sign up with your email to follow new studies for KNOWN OR HIGHLY SUSPECTED BODY (EXCLUDING CNS) LESION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New MRI dye aims to sharpen cancer detection

Diagnosis Not yet recruiting

This study is testing a new contrast agent called mangaciclanol for MRI scans. It aims to help doctors see and diagnose suspicious areas (lesions) in the brain or body more clearly than with the current standard agent. The trial will enroll 640 adults who are already scheduled fo…

Matched conditions: KNOWN OR HIGHLY SUSPECTED BODY (EXCLUDING CNS) LESION

Phase: PHASE2, PHASE3 • Sponsor: GE Healthcare • Aim: Diagnosis

Last updated Mar 30, 2026 14:31 UTC

KNOWN OR HIGHLY SUSPECTED BODY (EXCLUDING CNS) LESION

Get alerted when new KNOWN OR HIGHLY SUSPECTED BODY (EXCLUDING CNS) LESION trials appear

New MRI dye aims to sharpen cancer detection